Aarti Pharmalabs Limited
Mumbai, India
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: Aarti Pharmalabs Limited
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Mumbai, India
- Modalities
- Small Molecule API, Steroid / Corticosteroid API, HPAPI, Anti-cancer / Cytotoxic API, Xanthine Derivatives, NCE Drug Substance
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Aarti Pharmalabs Limited
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSmall Molecule API, Steroid / Corticosteroid API, HPAPI, Anti-cancer / Cytotoxic API, Xanthine Derivatives, NCE Drug Substance
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (6 modalities)
Recent News 10 articles
Aarti Pharmalabs Q3FY26 Results and Earnings Call Recording Now Available - scanx.trade
Aarti Pharmalabs expands Xanthine derivatives capacity to 9600 TPA - scanx.trade
Aarti Pharmalabs In Focus After Q4 Consolidated Profits Plunge 31% Despite Stable Top-line Traction - Trade Brains
Aarti Pharmalabs Commissions New Manufacturing Block at Tarapur - Machine Maker
Aarti Pharmalabs sets up R&D Centre in Navi Mumbai - Indian Pharma Post
Aarti Pharmalabs inaugurates phase 1 of greenfield manufacturing facility - Indian Pharma Post
Aarti Pharmalabs: Can its CDMO bet revive growth after a weak year? - The Indian Express
Aarti Pharmalabs targets 15-18% revenue and EBITDA growth over 3-4 years - scanx.trade
Aarti Pharmalabs Limited Clarifies Delay in Regulatory Disclosure to BSE - scanx.trade
AARTI PHARMALABS LIMITED Share Price Today - Live AARTIPHARM Stock Price for NSE/BSE - Upstox
Frequently Asked Questions About Aarti Pharmalabs Limited
What is Aarti Pharmalabs Limited's CDMO Signal Score?
Aarti Pharmalabs Limited has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Aarti Pharmalabs Limited for a manufacturing program?
Use the free AI matchmaker to compare Aarti Pharmalabs Limited against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Sai Life Sciences
Hyderabad, India
Small Molecule API, Complex Small Molecules, HPAPI, ADC, Peptides, Oligonucleotides, Lipids / LNP, Intermediates, Drug Discovery (CRO)
Fermion (Orion Group)
Espoo, Finland
Small Molecule API, HPAPI, Semi-solid drug product (creams, gels, ointments), Hormonal products
Veranova
Devens, MA
Small Molecule API, HPAPI, ADC payload/linker, Oligonucleotide, Peptide
Cambrex Corporation
East Rutherford, NJ
Small Molecule API, HPAPI, Controlled Substances, Oral Solid Dose, Solid State Research, Particle Engineering, Drug Product (OSD), Controlled Release
Ardena
Ghent, Belgium
Small Molecule API, Solid-State Research, HPAPI, PROTACs / Molecular Glues, Nanomedicine / LNP, Drug Product (Oral, Injectable, Semi-solid), CMC Regulatory, Bioanalysis